Literature DB >> 1632688

Formal hepatic resection of colorectal liver metastases. Ploidy and prognosis.

D S Lind1, G A Parker, J S Horsley, M J Kornstein, J P Neifeld, H D Bear, W Lawrence.   

Abstract

Fifty consecutive patients who underwent 52 formal hepatic resections (excluding isolated wedge resections) for metastatic colorectal cancer were analyzed to determine whether DNA content was of prognostic significance. The Dukes' stages of the colorectal primaries were: A (10%), B (20%), C (40%), D (28%), and unknown in 2%. Four patients whose liver metastases were discovered at the time of resection of the primary bowel cancer underwent concomitant liver resection, and the remaining patients underwent delayed resections. The hepatic resections performed were right lobectomy (50%), extended right lobectomy (19%), left lobectomy (13%), left lateral segmentectomy (6%), left lobectomy and right wedge (6%), extended left lobectomy (4%), and right lobectomy and left wedge (2%). The overall morbidity rate was 29%. The in-hospital mortality rate was 9%. As of November 1991, 36 patients have recurred. The 5-year actuarial survival was 28%. Flow cytometry could be performed on 37 archival specimens, 15 of which were found to be diploid whereas 22 were aneuploid. All metastases from Dukes A colorectal primaries demonstrated a diploid DNA content. In addition, there was no difference in actuarial survival between diploid and aneuploid tumors. These data suggest that in selected patients, formal hepatic resection of colorectal liver metastases can be performed with an acceptable morbidity rate, mortality rate, and survival, but ploidy of the resected tumor is not of prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632688      PMCID: PMC1242529          DOI: 10.1097/00000658-199206000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  27 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

Review 2.  Hepatic resection for metastases from colorectal carcinoma is of dubious value.

Authors:  W Silen
Journal:  Arch Surg       Date:  1989-09

Review 3.  Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.

Authors:  D E Merkel; W L McGuire
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

4.  Flow-cytometric analysis of colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis.

Authors:  A Yamaguchi; T Ishida; S Takegawa; G Nishimura; M Kanno; T Kosaka; Y Yonemura; R Izumi; I Miyazaki
Journal:  Oncology       Date:  1990       Impact factor: 2.935

5.  A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584.

Authors:  G Steele; R Bleday; R J Mayer; A Lindblad; N Petrelli; D Weaver
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

6.  A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver.

Authors:  L D Wagman; M M Kemeny; L Leong; J J Terz; L R Hill; J D Beatty; W A Kokal; D U Riihimaki
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

7.  The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases.

Authors:  R N Younes; A Rogatko; M F Brennan
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

8.  Segmentectomies in the management of liver tumors.

Authors:  D Franco; C Smadja; F Kahwaji; D Grange; F Kemeny; O Traynor
Journal:  Arch Surg       Date:  1988-04

Review 9.  DNA content in human cancer. Application in pathology and clinical medicine.

Authors:  D Seckinger; E Sugarbaker; O Frankfurt
Journal:  Arch Pathol Lab Med       Date:  1989-06       Impact factor: 5.534

10.  Intraoperative ultrasound of the liver affects operative decision making.

Authors:  G A Parker; W Lawrence; J S Horsley; J P Neifeld; D Cook; J Walsh; W Brewer; M J Koretz
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

View more
  5 in total

Review 1.  Evolving management of colorectal cancer.

Authors:  Jochem van der Voort van Zijp; Harald J Hoekstra; Marc D Basson
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 2.  Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.

Authors:  G Scott Gazelle; M G Myriam Hunink; Karen M Kuntz; Pamela M McMahon; Elkan F Halpern; Molly Beinfeld; Jessica S Lester; Kenneth K Tanabe; Milton C Weinstein
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

3.  [Resection of liver metastases of colorectal tumors. A uni- and multivariate analysis of prognostic factors].

Authors:  J K Seifert; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1996

Review 4.  Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  Curr Oncol Rep       Date:  2007-05       Impact factor: 5.075

5.  Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases.

Authors:  A Russo; M Migliavacca; V Bazan; N Maturi; V Morello; G Dardanoni; G Modica; P Bazan; I Albanese; M La Farina; R M Tomasino
Journal:  Cell Prolif       Date:  1998 Jun-Aug       Impact factor: 6.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.